S517-1473 Screening compound: 6-[(3-{4-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]piperidine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one

S517-1473 Screening compound: 6-[(3-{4-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]piperidine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one
S517-1473 Screening compound: 6-[(3-{4-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]piperidine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S517-1473
6-[(3-{4-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]piperidine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S517-1473

Molecular Formula

C24H32N6O5S (C24 H32 N6 O5 S)

Compound Name

6-[(3-{4-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]piperidine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-2,3-dihydro-1,3-benzoxazol-2-one

IUPAC name

6-[(3-{4-[(4-ethyl-4H-124-triazol-3-yl)methyl]piperidine-1-carbonyl}piperidin-1-yl)sulfonyl]-3-methyl-23-dihydro-13-benzoxazol-2-one

SMILES

CCn1c(CC(CC2)CCN2C(C(CCC2)CN2S(c(cc2)cc(O3)c2N(C)C3=O)(=O)=O)=O)nnc1

InChI

InChI=1S/C24H32N6O5S/c1-3-28-16-25-26-22(28)13-17-8-11-29(12-9-17)23(31)18-5-4-10-30(15-18)36(33,34)19-6-7-20-21(14-19)35-24(32)27(20)2/h6-7,14,16-18H,3-5,8-13,15H2,1-2H3/t18-/m0/s1

InChI Key

VEDOJRWKLQIODU-SFHVURJKSA-N

MDL Number (MFCD)

MFCD29011969

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

516.62

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

1.143

Distribution Coefficient, logD

1.139

Water Solubility, LogSw

-2.49

Polar Surface Area

96.454

Acid Dissociation Constant (pKa)

21.12

Base Dissociation Constant (pKb)

5.37

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

58.30

S517-1473 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with S517-1473 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S517-1473?
Check Price and Availability of S517-1473, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S517-1473 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S517-1473
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S517-1473
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S517-1473 available by request